What's Buzzing on Street: New Research on CorMedix, American Apparel, Horizon, Nike and Amazon

NEW YORK, December 29, 2014 /PRNewswire/ --

Moments ago, Analysts Review released new research updates concerning several important developing situations including CorMedix (NYSE MKT: CRMD), American Apparel (NYSE MKT: APP), Horizon (NASDAQ: HZNP), Nike (NYSE: NKE), and Amazon (NASDAQ: AMZN). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.

To access our full PDF reports on a complementary basis, please visit the links below.

--

Today's update concerns the following companies:

============

Full PDF Download Links (you may have to copy and paste the following links into your browser):

CRMD Research Report: ( http://get.analystsreview.com/pdf/?c=CorMedix&d=29-Dec-2014&s=CRMD ),

APP Research Report: ( http://get.analystsreview.com/pdf/?c=American%20Apparel&d=29-Dec-2014&s=APP ),

HZNP Research Report: ( http://get.analystsreview.com/pdf/?c=Horizon&d=29-Dec-2014&s=HZNP ),

NKE Research Report: ( http://get.analystsreview.com/pdf/?c=Nike&d=29-Dec-2014&s=NKE ),

AMZN Research Report: ( http://get.analystsreview.com/pdf/?c=Amazon&d=29-Dec-2014&s=AMZN ).

============

--

Analyst Update: Agreements, Strategic Review of Options, Lawsuit, Product Launch, and Performance Updates

Reviewed by: Rohit Tuli, CFA®  

The U.S. stock market prolonged its winning streak on Friday, ending the day in green, as positive sentiments continued to buoy the markets after the Christmas holiday. The Dow Jones Industrial Average (DJIA) gained for seven consecutive trading days and ended the session at 18,053.71, up 0.13%, while the S&P 500 moved up 0.33% to 2088.77. The Nasdaq Composite advanced 0.70% and closed at 4,806.86, its highest level since March 2000. The European markets will remain close till Monday. The Asian stocks were mostly higher, as investors played down a slew of Japanese economic reports on inflation, industrial output and the labor market.  The data showed that inflation in Japan was slowing, despite efforts of increasing it; however, the market reaction to the November figures was largely muted.

Shares of CorMedix, Inc. (CorMedix) rose for the second consecutive trading session on Friday, December 26, after the Company expanded its reach into the Middle East via a distribution agreement with distributor Arabian Trade House for the lead product Neutrolin in the Kingdom of Saudi Arabia. Find out more about CorMedix's latest distribution agreement in Saudi Arabia and the potential it holds for the Company's lead product in our exclusive research report.

Reports have surfaced that the U.S. based clothing retailer has come under pressure from British buyout firm Lion Capital to explore strategic options including a sale. Lion Capital has warrants to purchase up to 12% of American Apparel. Read more about latest developments on American Apparel which has been struggling to contain losses and boost sales in our research report.

Ireland-based Horizon Pharma PLC (Horizon) has filed a patent infringement lawsuit against Watson Laboratories, Inc. (WLF) and certain of its affiliated companies, Actavis, plc, and Actavis Inc., in order to prevent WLF from commercializing its generic version of PENNSAID 2% w/w. The lawsuit was filed within 45 days of WLF filing its Abbreviated New Drug Application (ANDA) with the US FDA. Get to know more about Horizon's lawsuit seeking to block WLF's ANDA for PENNSAID, used for treating the pain of osteoarthritis of the knee(s), in our exclusive research report.

The world's largest sportswear maker Nike Inc. (Nike) is marking the end of year 2014 with the launch of latest colorways of two of its signature shoes - the LeBron 12 'Trillion Dollar Man' and the Kobe 9 'Black Mamba'. Nike's new LeBron 12 is launching on December 30, 2014 followed by Kobe 9 KRM EXT on December 31, 2014. Find out more about the Nike's latest offerings in our comprehensive report.

The U.S. based online retailer Amazon.com Inc. (Amazon) is looking forward to end 2014 on a high note as the Company's Amazon Prime program garners an overwhelming response worldwide, with more than 10 million new members trying this fast, free shipping service this holiday season. This season, Amazon customers ordered more than 10 times as many items with Same-Day Delivery, over 2013. Find out more about Amazon Prime's latest holiday numbers and the Company's plans for 2015 in our research report.

--

About Analysts Review  

At Analysts Review, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

Analysts Review was designed for investors. By providing the best information available, we have set ourselves apart as one of the premier online investor communities.

--

Editor Note: This is not company news. We are an independent source and our views do not reflect the companies mentioned.

Compliance Procedure: Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA®. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

Further Resources: For more information about this release including editorial notes, compliance procedures and legal disclosures, please visit: http://www.analystsreview.com/editors

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review